zalcitabine has been researched along with Dermatitis Medicamentosa in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bascuñana, A; Laguna, F; Ocaña, I; Pulido, F | 1 |
| Boschini, A; Calista, D | 1 |
| Broder, S; Lawley, TJ; McNeely, MC; Yarchoan, R | 1 |
1 review(s) available for zalcitabine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
[Anti-retroviral treatment. Treatment modification: toxicity management].
Topics: Anti-HIV Agents; Didanosine; Drug Eruptions; Drug Therapy, Combination; Gastrointestinal Diseases; Hematologic Diseases; HIV Infections; Humans; Muscular Diseases; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1996 |
2 other study(ies) available for zalcitabine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cutaneous side effects induced by indinavir.
Topics: Adult; Alopecia; Didanosine; Drug Eruptions; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Middle Aged; Pruritus; Pyoderma Gangrenosum; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Scalp Dermatoses; Skin; Stavudine; Zalcitabine; Zidovudine | 2000 |
Dermatologic complications associated with administration of 2',3'-dideoxycytidine in patients with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Administration Schedule; Drug Eruptions; Drug Evaluation; HIV Antigens; Humans; Male; Middle Aged; Mouth Diseases; T-Lymphocytes, Helper-Inducer; Ulcer; Zalcitabine | 1989 |